Claros Technologies Secures $55 Million in Latest Series B Funding Round

Claros Technologies secured $55 million in its latest Series B, adding another data point to the Healthcare & Life Sciences funding market.

Claros Technologies Raises $55 million in Funding

Claros Technologies Raises $55 Million Series B Financing to Accelerate Global Commercialization of PFAS Destruction Technology. About Claros Technologies Founded in 2018 and based in the United States in Minneapolis, Minnesota, Claros Technologies is a global leader in PFAS mitigation, with two core divisions.

Investors Behind the Funding

The round was backed by Treehouse Family Capital LLC. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Claros Technologies operates in Healthcare & Life Sciences. Claros Technologies's financing adds to recent private-market activity.

Strategic Use of Funds

Accelerate Global Commercialization of PFAS Destruction Technology.

Looking Ahead

Jack Cogen, Manager of Treehouse Family Capital LLC, added:

Source reference: original announcement/article.